Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4 Week Randomized Double-blind Parallel Group Active Comparator Controlled Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis

NCT00403559 is registered in ClinicalTrials.gov with Dermatology Specialists Research as lead sponsor.

NCT NCT00403559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4 Week Randomized Double-blind Parallel Group Active Comparator Controlled Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis
Lead sponsor
Dermatology Specialists Research
Phase
Phase 2
Overall status
Completed
Start date
May 7, 2007
Completion date
February 27, 2009
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

seborrheic dermatitis